Brief: Hemcheck Sweden Q3 Pretax Profit Increases To SEK 2.6 Million
Nov 20 (Reuters) - Hemcheck Sweden AB HEMC.ST :
* Q3 OPERATING REVENUE SEK 110,718
* Q3 PRETAX PROFIT SEK 2.6 MILLION VERSUS SEK 1.2 MILLION
YEAR AGO
Source text for Eikon: ID:nWkr94PhCT
Further company coverage: HEMC.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Bio Vitos Pharma AB
See all newsAdvisory: Alerts on Bio Vitos Pharma withdrawn
Brief: Bio Vitos Pharma Q4 Operating Revenue Falls To SEK 0.3 Mln
Brief: Bio Vitos Reaches Settlement With Norvolt AS, Norvolt Capital AS
Brief: Bio Vitos Pharma Appoints Sven Rohmann As Acting CEO
Brief: Bio Vitos Pharma Q3 Loss After Financial Items SEK 3.0 Mln